series-c-plus
Stage
2014
Founded
1
Investors
About
Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company developing azenosertib, an investigational oral WEE1 kinase inhibitor, targeting ovarian and other cancers.
Explore Zentalis Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.